GE Healthcare launches Venue 40, a portable miniaturized ultrasound system

NewsGuard 100/100 Score

GE is helping to transform the delivery of patient care with Venue 40, a miniaturized ultrasound system with advanced touch-screen technology, launched by GE Healthcare, a business unit of General Electric Company (NYSE: GE). Venue 40 is portable, allowing physicians to quickly perform rapid diagnostics and needle-guided procedures right at a patient’s bedside, providing real-time results. Whether it is being used in the emergency room, operating room or sports medicine clinic, the lightweight system can be easily transported from location to location, offers high-resolution imaging, and is easy to both use and clean. Venue 40 is the first new-to-market product validated under GE’s healthymagination initiative, dedicated to improving the quality, access and cost of healthcare.

“The Venue 40 is a powerful, user-friendly ultrasound system that is helping to transform the patient experience by enabling doctors to deliver quality care at the patient bedside,” said Omar Ishrak, President and CEO of GE Healthcare Systems. “Services delivered at the point of care allow doctors to spend more time with their patients and can help enhance patient comfort and reduce anxiety. Venue 40 development is part of GE’s commitment to driving efficiencies in healthcare through technology that helps yield more rapid diagnosis, improved patient experiences and better outcomes.”

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Can generative AI truly transform healthcare into a more personalized experience?